Concepedia

Tolga Baykal

TB

Statistics

Publications

2

Citations

552

H-Index

2

Active since

2014

Affiliations

Medizinische Hochschule Hannover(Current)

Tolga Baykal is an author at Medizinische Hochschule Hannover specializing in antiviral therapy, hepatitis pharmacotherapy, and infectious diseases.

Publications per year

2014–2014

2

Publications

2

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

Stefan Zeuzem, Ira M. Jacobson, Tolga Baykal et al. · New England Journal of Medicine · 2014 · 519 citations · Full text

, , +17

O58 RESULTS FROM THE PHASE 2 PEARL-I STUDY: INTERFERON-FREE REGIMENS OF ABT-450/R + ABT-267 WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 4 INFECTION

Christophe Hézode, Patrick Marcellin, Stanislas Pol et al. · Journal of Hepatology · 2014 · 33 citations

, , +12

1–2 of 2